FindTrial
Sign In

Role of Neuron Specific Enolase in prognostication of Traumatic Brain Injury and Ischaemic Brain Injury

Predicitve value of the brain biomarker Neuron Specific Enolase in prognostication of patients with Traumatic and Ischemic Brain Injury - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/07/071047
Enrollment
50
Registered
2024-07-23
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G936- Cerebral edema

Interventions

Control Intervention1: Nil: Nil

Sponsors

Medicover Hospitals
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 All patients with TBI of moderate to severe grades as defined by BTF guidelines presenting with in 24hrs of injury 2 All patients with Acute Ischaemic Stroke with ASPECTS score less than 6 presenting with in 24hrs of symptoms

Exclusion criteria

Exclusion criteria: 1 Age less than 18 years 2 Pregnancy 3 Recent Neurosurgery less than 12 weeks 4 No consent

Design outcomes

Primary

MeasureTime frame
Predictive valu of Neuron Specific Enolase ICU mortality in ICUTimepoint: At time of admission and after 24hrs of first sample—

Secondary

MeasureTime frame
GCOS at ICU discharge Hospital Mortality GCOS at hospital discharge 28 day Mortality 90 day MortalityTimepoint: At 28days , 90 days—

Countries

India

Contacts

Public ContactDr Kesireddy Venkata Kalyan

Medicover Hospitals

drganshyam@gmail.com9949001344

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026